Processing 00000000.tx.1: Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease Jonathan A. 

Phrase: "Somatic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C2986476:Somatic [Qualitative Concept]
   907 E C0599444:soma [Cell Component]
   907 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   893 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "germline mosaicism in sporadic early-onset Alzheimer's disease Jonathan A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0026578:Mosaicism [Organism Attribute]
   739   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   739   C2987512:mosaicism [Organism]
Processing 00000000.tx.2: Beck1, Mark Poulter1, Tracy A. 

Phrase: "Beck1,"

Phrase: "Mark Poulter1,"

Phrase: "Tracy A."
Processing 00000000.tx.3: Campbell1, James B. 

Phrase: "Campbell1,"

Phrase: "James B."
Processing 00000000.tx.4: Uphill1, Gary Adamson1, Jennian F. 

Phrase: "Uphill1,"

Phrase: "Gary Adamson1,"

Phrase: "Jennian F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.5: Geddes3, Tamas Revesz2, Mary B. 

Phrase: "Geddes3,"

Phrase: "Tamas Revesz2,"

Phrase: "Mary B."
Processing 00000000.tx.6: Davis2, Nicholas W. 

Phrase: "Davis2,"

Phrase: "Nicholas W."
Processing 00000000.tx.7: Wood2, John Collinge1,* and Sarah J. 

Phrase: "Wood2,"

Phrase: "John Collinge1,"

Phrase: "*"

Phrase: "and"

Phrase: "Sarah J."
Processing 00000000.tx.8: Tabrizi1 1MRC Prion Unit and Department of Neurodegenerative Disease and 2Department of Molecular Neuroscience, Institute of Neurology UCL, Queen Square, London WC1N 3BG, UK and 3Department of Histopathology and Morbid Anatomy, Royal London Hospital, Whitechapel, London, UK Received January 21, 2004; 

Phrase: "Tabrizi1 1MRC Prion Unit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439148:Unit [Quantitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]

Phrase: "and"

Phrase: "Department of Neurodegenerative Disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "2Department of Molecular Neuroscience,"

Phrase: "Institute of Neurology UCL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Queen Square,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205120:Square [Spatial Concept]
   861   C1552595:Square [Intellectual Product]

Phrase: "London WC1N 3BG,"

Phrase: "UK"

Phrase: "and"

Phrase: "3Department of Histopathology"

Phrase: "and"

Phrase: "Morbid Anatomy,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0002808:Anatomy [Biomedical Occupation or Discipline]
   861   C0700276:anatomy [Anatomical Structure]
   861   C1384516:anatomy [Qualitative Concept]
   789 E C0220784:Anatomical [Qualitative Concept]

Phrase: "Royal London Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Whitechapel,"

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "January 21,"

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.9: Revised April 6, 2004; 

Phrase: "Revised April 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.10: Accepted April 19, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alzheimer's disease (AD) is the commonest neurodegenerative disease worldwide. 

Phrase: "Accepted April 19,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "the commonest neurodegenerative disease worldwide."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: Rare familial cases may be caused by mutations in one of three genesamyloid precursor protein, presenilin-1 and presenilin-2; 

Phrase: "Rare familial cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of three genesamyloid precursor protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.12: however, the molecular basis of >99% of AD cases is unknown. 

Phrase: "however,"

Phrase: "the molecular basis of >99% of AD cases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C1853126:MOLECULAR BASIS [Idea or Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1527178:Basis [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   744   C1874451:Basis [Pharmacologic Substance]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.13: Somatic mutation has been considered to be a mechanism that may account for a proportion of sporadic cases of AD, but to date there has been no evidence for this. 

Phrase: "Somatic mutation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0544886:Somatic mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2986476:Somatic [Qualitative Concept]
   768 E C0599444:soma [Cell Component]
   768 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "account for a proportion of sporadic cases of AD,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0205422:Sporadic [Temporal Concept]
   742   C0868928:Cases [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   742   C1551359:account [Idea or Concept]
   742   C1709707:Proportion [Quantitative Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "but to date there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011008:Date [Temporal Concept]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C2348077:Date [Food]

Phrase: "has"

Phrase: "been"

Phrase: "no evidence for this."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.14: We now report a sporadic early-onset patient with AD, and show that this individual is a somatic mosaic for a mutation in the presenilin-1 gene, suggesting a novel molecular mechanism for AD. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a sporadic early-onset patient with AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "is"

Phrase: "a somatic mosaic for a mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439750:Mosaic [Spatial Concept]
   753   C0700058:Mosaic [Intellectual Product]
   753   C2987512:Mosaic [Organism]

Phrase: "in the presenilin-1 gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a novel molecular mechanism for AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.15: Quantification of the mosaicism demonstrated the degree of mosaicism at 8% in peripheral lymphocytes and 14% in cerebral cortex in the index patient; 

Phrase: "Quantification of the mosaicism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "the degree of mosaicism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "at 8%"

Phrase: "in peripheral lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "14% in cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "in the index patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: ";"
Processing 00000000.tx.16: a clear gene dosage effect on age of presentation and clinical phenotypic presentation is demonstrated. 

Phrase: "a clear gene dosage effect on age of presentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "clinical phenotypic presentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2708283:Clinical presentation [Intellectual Product]
   827   C0449450:Presentation [Idea or Concept]

Phrase: "is"

Phrase: "demonstrated."
Processing 00000000.tx.17: This finding has important implications for the aetiology of sporadic AD, and for other apparently sporadic neurodegenerative diseases such as Parkinson's disease, motor neuron disease and CreutzfeldtJakob disease.  

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "has"

Phrase: "important implications for the aetiology of sporadic AD,"

Phrase: "and for other apparently sporadic neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0205422:Sporadic [Temporal Concept]
   748   C0750541:apparently [Idea or Concept]
   748   C1515981:And [Idea or Concept]

Phrase: "such as Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "motor neuron disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0085084:Motor Neuron Disease [Disease or Syndrome]
   901   C0026609:Motor neuron [Cell]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0027882:Neuron [Cell]
   827   C1513492:Motor [Functional Concept]
   827   C1705994:Motor [Manufactured Object]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "CreutzfeldtJakob disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.18: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized clinically by memory impairment, language and visuo-spatial problems and personality changes, followed by global cognitive decline. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "a progressive neurodegenerative disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0677932:progressive disease [Neoplastic Process]
   913   C1335499:Progressive Disease [Finding]
   913   C3539781:Progressive Disease [Disease or Syndrome]
   901   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "clinically by memory impairment,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0233794:Memory impairment [Mental or Behavioral Dysfunction]
   833   C1963167:Memory impairment [Finding]
   770   C0025260:Memory [Mental Process]
   770   C0684336:Impairment [Pathologic Function]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   715 E C0679055:mnemonic [Mental Process]

Phrase: "language"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023008:Language [Language]

Phrase: "and"

Phrase: "visuo-spatial problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1546466:Problems [Idea or Concept]
   793 E C0033213:Problem [Finding]

Phrase: "and"

Phrase: "personality changes,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0240735:Personality changes [Sign or Symptom]
   861   C0003944:personality [Mental or Behavioral Dysfunction]
   861   C0031208:Personality [Mental Process]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "followed by global cognitive decline."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   760   C0205246:Global [Spatial Concept]
   760   C1516691:Cognitive [Functional Concept]
   760   C2348867:Global [Qualitative Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.19: It accounts for up to 70% of all late-onset cases of dementia, with a prevalence of 4% at 75 years. 

Phrase: "It"

Phrase: "accounts for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1551359:account [Idea or Concept]
   833   C2741673:Account # [Clinical Attribute]
   833   C2981730:Account [Classification]

Phrase: "up to 70%"

Phrase: "of all late-onset cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "of dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with a prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "of 4%"

Phrase: "at 75 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.20: With the prediction of 1 billion people in the world over 60 years old by 2025, AD represents a major public health concern. 

Phrase: "With the prediction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:Prediction [Idea or Concept]

Phrase: "of 1 billion people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027361:People [Population Group]

Phrase: "in the world"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700280:World [Population Group]

Phrase: "over 60 years old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "by 2025,"

Phrase: "AD"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a major public health concern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2699424:Concern [Idea or Concept]
Processing 00000000.tx.21: Neuropathologically it is characterized by the accumulation in the brain of extracellular -amyloid plaques and neurofibrillary tangles with neurons of the cerebral cortex and hippocampus. 

Phrase: "Neuropathologically"

Phrase: "it"

Phrase: "is"

Phrase: "characterized by the accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterized [Activity]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of extracellular -amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangles with neurons of the cerebral cortex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   737 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.22: The molecular basis of >99% of AD is unknown, but mutations in three genes have been found associated with 50% of autosomal dominant, early-onset (<65 years) familial ADthe amyloid precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2) (13). 

Phrase: "The molecular basis of >99% of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1853126:MOLECULAR BASIS [Idea or Concept]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "mutations in three genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "associated with 50% of autosomal dominant, early-onset"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0443147:Autosomal dominant [Intellectual Product]
   770   C1833334:Early-onset [Finding]
   744   C0332162:Onset [Qualitative Concept]
   744   C0596142:autosomal [Cell Component]
   744   C1279919:Early [Temporal Concept]
   744   C1527180:Dominant [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "("

Phrase: "<65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "familial ADthe amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "presenilin 1 (PSEN1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin 2 (PSEN2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.23: These genes have provided important mechanistic insights into the pathophysiology of AD. 

Phrase: "These genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "provided important mechanistic insights into the pathophysiology of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:insights [Mental Process]
Processing 00000000.tx.24: The presenilins are components of novel enzyme complexes involved in the physiological -secretase proteolytic cleavage of APP; 

Phrase: "The presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "components of novel enzyme complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "involved in the physiological -secretase proteolytic cleavage of APP"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   785   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   785   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0597304:Protein Cleavage [Molecular Function]
           Proteolytic
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0010813:cleavage [Cell Function]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205463:Physiological [Functional Concept]
   736   C0596311:Cleavage [Phenomenon or Process]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1314939:Involved [Functional Concept]
   736   C1330957:cleavage [Cell Function]
   736   C1709634:Precursor [Idea or Concept]
   736   C1947941:proteolytic [Enzyme]

Phrase: ";"
Processing 00000000.tx.25: mutations in PSEN1 and PSEN2 affect the precision of -secretase cleavage with resultant increased formation of the neurotoxic isoform of A (A 42), the major component of -amyloid plaques (4). 

Phrase: "mutations in PSEN1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "PSEN2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the precision of -secretase cleavage with resultant increased formation of the neurotoxic isoform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0010813:cleavage [Cell Function]
   735   C0596311:Cleavage [Phenomenon or Process]
   735   C1330957:cleavage [Cell Function]

Phrase: "of A ("

Phrase: "A 42"

Phrase: ")"

Phrase: ","

Phrase: "the major component of -amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   840   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   840   C2936349:Plaques, Amyloid [Acquired Abnormality]
   771 E C0011389:Plaque [Disease or Syndrome]
   771 E C0332461:Plaque [Finding]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.26: Inheritance of the APOE*E4 allele has been shown to confer increased risk of AD (5,6), but the search for other genes causing sporadic and late-onset AD has been difficult (7). 

Phrase: "Inheritance of the APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242538:Inheritance [Quantitative Concept]
   770   C0728826:Inheritance [Functional Concept]

Phrase: "*E4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "increased risk of AD (5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the search for other genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "late-onset AD"

Phrase: "has"

Phrase: "been"

Phrase: "difficult"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.27: Germline and somatic mosaicism have emerged as important factors in the aetiology of cancer, ageing and mitochondrial disorders; 

Phrase: "Germline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017473:Germ Line [Cell]

Phrase: "and"

Phrase: "somatic mosaicism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "have"

Phrase: "emerged as important factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "in the aetiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "ageing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "mitochondrial disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751651:Mitochondrial Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.28: they are also recognized causes of the marked phenotypic variation seen in a number of monogenic diseases (8,9). 

Phrase: "they"

Phrase: "are"

Phrase: "also recognized causes of the marked phenotypic variation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0015127:causes [Functional Concept]
   744   C1314792:Causes [Functional Concept]
   711 E C1524003:Cause [Conceptual Entity]

Phrase: "seen in a number of monogenic diseases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0205397:Seen [Qualitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.29: Mosaicism for trisomy of chromosome 21 has been proposed as a cause of late-onset AD (10), and somatic mosaicism, with the development of specific disease-associated mutations in neuronal precursor cells, has been postulated as a possible cause of sporadic AD and other neurodegenerative disorders, but to date there has been no evidence for this in vivo. 

Phrase: "Mosaicism for trisomy of chromosome 21"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0333677:Chromosome mosaicism [Organism Attribute]
   753   C0026578:Mosaicism [Organism Attribute]
   753   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   753   C2987512:mosaicism [Organism]
   748 E C3495586:Mosaicism, Chromosomal [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "proposed as a cause of late-onset AD (10"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0015127:cause [Functional Concept]
   742   C0205087:Late [Temporal Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C1441414:PROPOSED [Idea or Concept]
   742   C1524003:Cause [Conceptual Entity]
   742   C1553874:Proposed [Qualitative Concept]
   742   C1578820:Proposed [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "somatic mosaicism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "with the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of specific disease-associated mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in neuronal precursor cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0018956:precursor cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "postulated as a possible cause of sporadic AD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0015127:cause [Functional Concept]
   744   C0205422:Sporadic [Temporal Concept]
   744   C0332149:Possible [Qualitative Concept]
   744   C1524003:Cause [Conceptual Entity]
   744   C1705910:Possible [Qualitative Concept]
   744   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "other neurodegenerative disorders,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "but to date there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011008:Date [Temporal Concept]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C2348077:Date [Food]

Phrase: "has"

Phrase: "been"

Phrase: "no evidence for this in vivo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.30: Here we report the first description of somatic and germline mosaicism in a patient with sporadic early-onset AD; 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the first description of somatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678257:Description [Idea or Concept]

Phrase: "and"

Phrase: "germline mosaicism in a patient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026578:Mosaicism [Organism Attribute]
   760   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   760   C2987512:mosaicism [Organism]

Phrase: "with sporadic early-onset AD"

Phrase: ";"
Processing 00000000.tx.31: this finding also has important implications for the aetiology of other apparently sporadic neurodegenerative diseases.  

Phrase: "this finding also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "has"

Phrase: "important implications for the aetiology of other apparently sporadic neurodegenerative diseases."
Processing 00000000.tx.32: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The index patient (II.1, Fig.1) presented at the age of 52 with a 10-year history of progressive parkinsonian syndrome, with additional features of mild spastic paraparesis and dementia. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The index patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(II.1,"

Phrase: "Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "presented at the age of 52"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0001779:Age [Organism Attribute]
   753   C0449450:Presented [Idea or Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "with a 10-year history"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0019664:History [Occupation or Discipline]
   812   C0019665:history [Intellectual Product]
   812   C0262512:History, NOS [Organism Attribute]
   812   C0262926:History [Finding]
   812   C1705255:History [Conceptual Entity]
   812   C2004062:History [Finding]
   741 E C1552658:Historical [Idea or Concept]
   741 E C1552723:Historical [Idea or Concept]

Phrase: "of progressive parkinsonian syndrome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0242422:Parkinsonian Syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "with additional features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "of mild spastic paraparesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1847641:Mild paraparesis [Finding]
   901   C0037771:Paraparesis, Spastic [Sign or Symptom]
   827   C0221166:Paraparesis [Sign or Symptom]

Phrase: "and"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.33: She died at the age of 58 after a 16-year illness. 

Phrase: "She"

Phrase: "died at the age of 58"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011065:Died [Organism Function]
   753   C1546956:Died [Finding]

Phrase: "after a 16-year illness."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0221423:Illness [Finding]
   755 E C0231218:Ill [Sign or Symptom]
   755 E C0332271:worse [Qualitative Concept]
   755 E C1279889:Worse [Finding]
   755 E C1457868:Worse [Qualitative Concept]
   755 E C1522166:Worst [Qualitative Concept]
Processing 00000000.tx.34: A definitive diagnosis of early-onset (defined as onset <65 years) AD was only made post-mortem after neuropathological investigation of her brain revealed A immunoreactive senile plaques (classified as CERAD frequent), many of which were of the cotton wool type (Fig.2A), together with severe neurofibrillary tangle pathology (Braak and Braak stage VI) (11) (Fig.2B). 

Phrase: "A definitive diagnosis of early-onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0596473:Early Diagnosis [Diagnostic Procedure]
   753   C0011900:Diagnosis [Finding]
   753   C1704338:diagnosis [Qualitative Concept]
   753   C1704656:DIAGNOSIS [Research Activity]

Phrase: "("

Phrase: "defined as onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332162:Onset [Qualitative Concept]
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "<65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "AD"

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "post-mortem after neuropathological investigation of her brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004398:postmortem [Diagnostic Procedure]
   770   C0580205:Postmortem [Temporal Concept]
   770   C0848632:post mortem [Finding]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "A immunoreactive senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]

Phrase: "("

Phrase: "classified as CERAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0008902:Classified [Classification]

Phrase: "frequent"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0332183:Frequent [Temporal Concept]
   928 E C0376249:frequency [Quantitative Concept]
   928 E C0439603:Frequencies [Temporal Concept]
   928 E C0871396:Frequency [Quantitative Concept]
   928 E C1561548:Frequency [Qualitative Concept]
   928 E C1705502:Frequency [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "many of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439064:Many [Quantitative Concept]
   790   C0747726:many [Conceptual Entity]

Phrase: "were of the cotton wool type"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0440207:Cotton wool [Biomedical or Dental Material]
   753   C0010196:Cotton [Plant]
   753   C0043220:Wool [Substance]
   753   C0330523:cotton [Plant]
   753   C0330524:cotton [Plant]
   753   C0332307:Type [Qualitative Concept]
   753   C1095832:Cotton [Substance]
   753   C1547052:*Type [Quantitative Concept]
   753   C1561494:Wool [Intellectual Product]

Phrase: "(Fig.2A"

Phrase: ")"

Phrase: ","

Phrase: "together with severe neurofibrillary tangle pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   741 E C1521733:Pathologic [Functional Concept]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak stage VI) (11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205390:Stage [Temporal Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]

Phrase: ")"

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.35: Her daughter (III.2, Fig.1) presented at the age of 27 with a very different phenotype consisting of a progressive cerebellar syndrome, with spastic paraparesis and dementia, which suggested a different aetiology to her mother's disease; 

Phrase: "Her daughter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011011:Daughter [Family Group]
  1000   C1610715:Daughter [Intellectual Product]

Phrase: "(III.2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "presented at the age of 27"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0001779:Age [Organism Attribute]
   753   C0449450:Presented [Idea or Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "with a very different phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "consisting of a progressive cerebellar syndrome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007760:Cerebellar syndrome [Disease or Syndrome]
   753   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   753   C0039082:Syndrome [Disease or Syndrome]
   753   C0205329:Progressive [Functional Concept]
   753   C1707522:Cerebellar [Tissue]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "with spastic paraparesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037771:Paraparesis, Spastic [Sign or Symptom]
   861   C0221166:Paraparesis [Sign or Symptom]

Phrase: "and"

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "which"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a different aetiology to her mother's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1314792:disease etiology [Functional Concept]
           Aetiology
   748   C0015127:aetiology [Functional Concept]
   748   C1524003:Etiology [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.36: she died 12 years after diagnosis. 

Phrase: "she"

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: "12 years after diagnosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.37: Autopsy was not performed on patient III.2. 

Phrase: "Autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "performed on patient III.2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C0439070:III [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   760   C1705160:III [Qualitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.38: View larger version (9K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.39: Family pedigree indicating mosaic individual (speckled circle), affected heterozygous offspring (shaded circle) and unaffected siblings (open square or circle). 

Phrase: "Family pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:Pedigree [Intellectual Product]

Phrase: "indicating"

Phrase: "mosaic individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "(speckled circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282913:Circle [Spatial Concept]
   861   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "heterozygous offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "(shaded circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282913:Circle [Spatial Concept]
   861   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "unaffected siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037047:Siblings [Family Group]
   827 E C1611273:Sibling [Intellectual Product]

Phrase: "(open square"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205120:Square [Spatial Concept]
   861   C1552595:Square [Intellectual Product]

Phrase: "or"

Phrase: "circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282913:Circle [Spatial Concept]
  1000   C1551714:Circle [Population Group]

Phrase: ")."
Processing 00000000.tx.40: II.1 is the index patient (arrowed).  

Phrase: "II.1"

Phrase: "is"

Phrase: "the index patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(arrowed"

Phrase: ")."
Processing 00000000.tx.41: View larger version (78K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(78K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.42: (A and B) The major neuropathological findings of Alzheimer's disease in index patient II.1. 

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The major neuropathological findings of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]

Phrase: "in index patient II.1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0030705:*^patient [Patient or Disabled Group]
   812   C0918012:Index [Intellectual Product]
   812   C1552854:index [Idea or Concept]
   812   C1637833:% index [Quantitative Concept]
Processing 00000000.tx.43: Throughout the neocortical areas there was severe deposition of A peptide in parenchyma and blood vessels, the majority of these plaques were of the cotton wool type. 

Phrase: "Throughout the neocortical areas there"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "was"

Phrase: "severe deposition of A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "in parenchyma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "blood vessels,"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "the majority of these plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "were of the cotton wool type."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0440207:Cotton wool [Biomedical or Dental Material]
   753   C0010196:Cotton [Plant]
   753   C0043220:Wool [Substance]
   753   C0330523:cotton [Plant]
   753   C0330524:cotton [Plant]
   753   C0332307:Type [Qualitative Concept]
   753   C1095832:Cotton [Substance]
   753   C1547052:*Type [Quantitative Concept]
   753   C1561494:Wool [Intellectual Product]
Processing 00000000.tx.44: The inset shows a capillary sized vessel with A deposition (A). 

Phrase: "The inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a capillary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006901:Capillary [Body Part, Organ, or Organ Component]
  1000   C0935624:Capillary [Body Part, Organ, or Organ Component]
  1000   C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "sized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0456389:size [Spatial Concept]

Phrase: "vessel with A deposition"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005847:Vessel [Body Part, Organ, or Organ Component]
   770   C1511228:Vessel [Tissue]
   715 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.45: There were frequent neurofibrillary tangles (arrow), neuropil threads (double arrow) and plaque-associated abnormal neurites (arrowhead) demonstrated with the AT8 antibody recognizing phosphorylated serine 202/threonine 205 of tau (B). 

Phrase: "There"

Phrase: "were"

Phrase: "frequent neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "(double arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "plaque-associated abnormal neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0085103:Neurites [Cell Component]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "demonstrated with the AT8 antibody recognizing phosphorylated serine 202/threonine 205 of tau"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   735   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   735   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   735   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C1720655:Tau [Intellectual Product]
   735   C1947974:Tau [Research Activity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.46: (A) A immunohistochemistry, 6F/3D antibody, Dako, 1:100, bar represents 500m on the main panel and 50m on the inset. 

Phrase: "(A)"

Phrase: "A immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "6F/3D antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Dako,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100,"

Phrase: "bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "500m on the main panel"

Phrase: "and"

Phrase: "50m on the inset."
Processing 00000000.tx.47: (B) Tau immunohistochemistry, AT8 antibody, Innogenetics, 1:200, bar represents 75m.  

Phrase: "(B) Tau immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "AT8 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Innogenetics,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200,"

Phrase: "bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "75m."
Processing 00000000.tx.48: During the clinical investigation of the daughter III.2, sequencing of the PSEN1 gene was undertaken and revealed an exon 12 P436Q mutation (g. 71111C>A) in peripheral lymphocyte DNA (12). 

Phrase: "During the clinical investigation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1261322:Clinical investigation [Health Care Activity]
           Investigation
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "of the daughter III.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0011011:Daughter [Family Group]
   827   C0439070:III [Intellectual Product]
   827   C1610715:Daughter [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "sequencing of the PSEN1 gene"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1294197:Gene Sequencing [Laboratory Procedure]
   753   C0017337:Gene [Gene or Genome]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162326:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "undertaken"

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an exon 12 P436Q mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(g. 71111C"

Phrase: ">A) in peripheral lymphocyte DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0000702:A-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.49: No other sequence variation was detected in any of the other AD-associated genes (13), and prion protein (PRNP) genotyping was negative. 

Phrase: "No"

Phrase: "other sequence variation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0042333:Sequence Variation [Natural Phenomenon or Process]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0205419:Variation [Qualitative Concept]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "detected in any of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "other AD-associated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "prion protein (PRNP) genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1285573:Genotyping [Laboratory Procedure]
   734   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
   734   C1418941:PRION PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "negative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.50: Testing of both mother (II.1) and daughter (III.2) by direct sequencing and allele-specific oligonucleotide hybridization (ASOH) demonstrated an unexpected disproportionate ratio of mutant to wild-type signals. 

Phrase: "Testing of both mother"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]

Phrase: "(II.1"

Phrase: ")"

Phrase: "and"

Phrase: "daughter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011011:Daughter [Family Group]
  1000   C1610715:Daughter [Intellectual Product]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "by direct sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "and"

Phrase: "allele-specific oligonucleotide hybridization (ASOH)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "an unexpected disproportionate ratio of mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "to wild-type signals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1710082:Signal [Phenomenon or Process]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.51: We were unable to detect the mutant allele by direct sequencing using peripheral lymphocyte DNA extracted from whole blood, from II.1, the mother and our index patient (Fig.3C); 

Phrase: "We"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the mutant allele by direct sequencing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "peripheral lymphocyte DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from whole blood,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0370231:whole blood [Body Substance]
   833   C1546552:Blood, Whole [Intellectual Product]
   833   C1608383:Whole Blood [Body Substance]
   833   C1608936:Blood, Whole [Intellectual Product]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0229664:Blood [Body Substance]
   770   C0444667:Whole [Quantitative Concept]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "from II.1,"

Phrase: "the mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0026591:Mother [Family Group]
   944 E C1826438:MATER [Gene or Genome]
   944 E C2347083:Maternal [Family Group]

Phrase: "and"

Phrase: "our index patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.52: ASOH using the same DNA revealed a markedly reduced signal for the mutant allele (Fig.4). 

Phrase: "ASOH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a markedly reduced signal for the mutant allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.53: Similar tests for the daughter III.2 demonstrated the expected heterozygous patterns of wild-type to mutant signal (Figs3D and 4). 

Phrase: "Similar tests for the daughter III.2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0022885:Tests [Laboratory Procedure]
   748   C0392366:Tests [Intellectual Product]
   714 E C0039593:Test [Functional Concept]

Phrase: "demonstrated"

Phrase: "the expected heterozygous patterns of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "to mutant signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "(Figs3D"

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.54: We then investigated, by haplotype analysis using allele-specific PCR (asPCR) of peripheral lymphocyte DNA and DNA isolated from cerebral cortex, whether the disproportionate signals from individual II.1, in conjunction with the distinct clinical presentation in her daughter (III.2), were consistent with a somatic mutation. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "by haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "allele-specific PCR (asPCR) of peripheral lymphocyte DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "isolated from cerebral cortex,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   770   C0205409:Isolated [Functional Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   770   C2700441:Cortex [Plant]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "whether"

Phrase: "the disproportionate signals from individual II.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710082:Signal [Phenomenon or Process]

Phrase: "in conjunction with the distinct clinical presentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2708283:Clinical presentation [Intellectual Product]
   827   C0449450:Presentation [Idea or Concept]

Phrase: "in her daughter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011011:Daughter [Family Group]
  1000   C1610715:Daughter [Intellectual Product]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "consistent with a somatic mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.55: We performed pre-symptomatic genetic screening for individuals III.1 and III.4, as part of our molecular diagnostic service, which demonstrated that they were negative for the P436Q mutation (Fig.3A and B). 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pre-symptomatic genetic screening for individuals III.1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0017394:Genetic screening [Finding]
   770   C0813145:Genetic Screening [Diagnostic Procedure]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0220908:Screening [Health Care Activity]
   744   C0220909:screening [Functional Concept]
   744   C0314603:Genetic [Functional Concept]
   744   C1698960:screening [Intellectual Product]
   744   C1710031:Screening [Diagnostic Procedure]
   744   C1710477:SCREENING [Research Activity]
   711 E C1305399:screen [Functional Concept]
   711 E C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "III.4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "as"

Phrase: "part of our molecular diagnostic service,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "they"

Phrase: "were"

Phrase: "negative for the P436Q mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205160:Negative [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "(Fig.3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.56: Individual III.3 did not seek pre-symptomatic genetic testing. 

Phrase: "Individual III.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seek"

Phrase: "pre-symptomatic genetic testing."
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
   861   C0679560:Genetic Testing [Laboratory Procedure]
   812   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   812   C0039593:Testing [Functional Concept]
   812   C0314603:Genetic [Functional Concept]
   812   C0392366:testing [Intellectual Product]
   779 E C0022885:Test [Laboratory Procedure]
   756 E C0005615:Birth [Organism Function]
   756 E C0035150:Reproduction [Organism Function]
   756 E C0079946:origin [Classification]
   756 E C0439659:Origin [Temporal Concept]
   756 E C1550512:origin [Intellectual Product]
   756 E C1550722:birth [Idea or Concept]
   756 E C3245487:birth [Intellectual Product]
   729 E C0454729:Natal [Geographic Area]
   729 E C0559522:Genital [Body System]
   729 E C1546649:Genital [Intellectual Product]
   729 E C1550642:Genital [Body Substance]
   719 E C0205313:Original [Idea or Concept]
   719 E C2347409:Original [Occupational Activity]
   701 E C0598240:originality [Mental Process]
Processing 00000000.tx.57: View larger version (47K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.58: (AE) This figure demonstrates the semiautomated fluorescent DNA sequencing results of PSEN1 exon 12. 

Phrase: "(AE)"

Phrase: "This figure"

Phrase: "demonstrates"

Phrase: "the semiautomated fluorescent DNA sequencing results of PSEN1 exon 12."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]
Processing 00000000.tx.59: Individuals III.1 and III.4 were both negative for the P436Q mutation (A and B). 

Phrase: "Individuals III.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "and"

Phrase: "III.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "were"

Phrase: "both negative for the P436Q mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "(A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.60: Sequencing of peripheral lymphocyte DNA in II.1 fails to detect the mutation (C); 

Phrase: "Sequencing of peripheral lymphocyte DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0162326:DNA sequencing [Nucleotide Sequence]
   797   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]

Phrase: "in II.1"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.61: however, heterozygosity of individual III.2 is clearly discernable (D). 

Phrase: "however,"

Phrase: "heterozygosity of individual III.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019425:Heterozygosity [Organism Attribute]

Phrase: "is"

Phrase: "clearly discernable (D)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205396:Discernible [Qualitative Concept]
Processing 00000000.tx.62: Cerebral cortex DNA from the mosaic II.1 demonstrates the limits of detection by this method of sequencing (E). 

Phrase: "Cerebral cortex DNA from the mosaic II.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "demonstrates"

Phrase: "the limits of detection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   909   C2718050:Limits of Detection [Quantitative Concept]
           Detection Limits
   770   C0439801:limits [Functional Concept]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "by this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.63: Weak incorporation of ddATP is just visible above the base line at the second position of codon 436, indicated by the arrow. 

Phrase: "Weak incorporation of ddATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "is"

Phrase: "just visible above the base line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205379:Visible [Qualitative Concept]

Phrase: "at the second position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "of codon 436,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "indicated by the arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.64: It is clearly discernable from artefacts, which manifest here as trailing peaks, and was consistently present in multiple samples from II.1 and not observed in any other sample (PL=peripheral lymphocyte DNA, CC=cerebral cortex DNA).  

Phrase: "It"

Phrase: "is"

Phrase: "clearly discernable from artefacts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205396:Discernible [Qualitative Concept]

Phrase: "which"

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "here"

Phrase: "as"

Phrase: "trailing peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "consistently"

Phrase: "present in multiple samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0150312:Present [Quantitative Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from II.1"

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in any"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "other sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "(PL=peripheral lymphocyte DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CC=cerebral cortex DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.65: View larger version (67K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(67K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.66: Allele-specific oligonucleotide hybridization demonstrating the disproportionate signals for patient II.1 DNA compared with heterozygote III.2 and wild-type individuals (PL=peripheral lymphocyte DNA, CC=cerebral cortex DNA, NTC=no template control).  

Phrase: "Allele-specific oligonucleotide hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "demonstrating"

Phrase: "the disproportionate signals for patient II.1 DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1710082:Signal [Phenomenon or Process]

Phrase: "compared with heterozygote III.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0019425:Heterozygote [Organism Attribute]
   760   C0439070:III [Intellectual Product]
   760   C1705160:III [Qualitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "wild-type individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(PL=peripheral lymphocyte DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CC=cerebral cortex DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "NTC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2755952:NTC [Cell Component]

Phrase: "="

Phrase: "no template control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.67: Heterozygosity at a single nucleotide polymorphism (SNP) position flanking the mutation in II.1 (see Materials and Methods and Fig.5A) allowed us to perform PCR using all combinations of two allele-specific forward primers, defining mutant and wild-type alleles, and two allele-specific reverse primers to allow identification of all four potential haplotypes (double asPCR) (Fig.5A). 

Phrase: "Heterozygosity at a single nucleotide polymorphism (SNP) position"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019425:Heterozygosity [Organism Attribute]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the mutation in II.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all combinations of two allele-specific forward primers,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0453882:Combinations [Manufactured Object]
   711 E C0205195:Combination [Qualitative Concept]
   711 E C1947911:Combination [Physical Object]

Phrase: "defining"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "wild-type alleles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Alleles [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "two allele-specific reverse primers to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   810   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   766   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "identification of all four potential haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "(double asPCR) (Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.68: The demonstration of two wild-type alleles and a third mutant allele in II.1 in different tissues indicates somatic mosaicism in this individual (Fig.5B). 

Phrase: "The demonstration of two wild-type alleles"

Phrase: "and"

Phrase: "a third mutant allele in II.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "in different tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "indicates"

Phrase: "somatic mosaicism in this individual"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1866227:Somatic mosaicism [Finding]
   760   C0026578:Mosaicism [Organism Attribute]
   760   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   760   C2987512:mosaicism [Organism]

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.69: The unaffected siblings inherited their mother's CT progenitor allele, whereas individual III.2 inherited the mutant AT allele. 

Phrase: "The unaffected siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037047:Siblings [Family Group]
   827 E C1611273:Sibling [Intellectual Product]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "their mother's CT progenitor allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "whereas"

Phrase: "individual III.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "the mutant AT allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.70: Extended haplotype analysis including data from six microsatellite markers, in addition to the allele-specific PCR data, was performed (Fig.5C). 

Phrase: "Extended haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "data from six microsatellite markers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "in addition to the allele-specific PCR data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig.5C"

Phrase: ")."
Processing 00000000.tx.71: All offspring, both affected (III.2) and unaffected (III.1, III.4), inherit the same microsatellite haplotype from individual II.1. 

Phrase: "All offspring,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "both"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "(III.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "III.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "inherit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:inherit [Functional Concept]

Phrase: "the same microsatellite haplotype from individual II.1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.72: These data, combined with the SNP haplotypes, are consistent with mosaicism in individual II.1, with the P436Q mutation on the progenitor A haplotype background generating haplotype A*. 

Phrase: "These data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "combined with the SNP haplotypes,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:Polymorphism [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0205195:Combined [Qualitative Concept]
   748   C1882417:Polymorphism [Qualitative Concept]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "are"

Phrase: "consistent with mosaicism"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "in individual II.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "with the P436Q mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on the progenitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870134:Progenitor [Family Group]

Phrase: "A haplotype background generating haplotype A"

Phrase: "*."
Processing 00000000.tx.73: Although sensitivity of DNA sequencing, compared with ASOH, did not allow for the detection of the mutant allele in DNA from peripheral lymphocytes, it was demonstrable using DNA extracted from cerebral cortex of II.1 (Fig.3E) at the limits of detection suggesting differing degrees of mosaicism between these two tissues. 

Phrase: "Although"

Phrase: "sensitivity of DNA sequencing,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "compared with ASOH,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0002085:Allele [Gene or Genome]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205369:Specific [Qualitative Concept]
   753   C1300517:Hybridization [Laboratory Procedure]
   753   C1552740:specific [Intellectual Product]
   753   C1707455:Compared [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "allow for the detection of the mutant allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0002085:Allele [Gene or Genome]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C0683607:allow [Social Behavior]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from peripheral lymphocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "it"

Phrase: "was"

Phrase: "demonstrable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332265:Demonstrable [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from cerebral cortex of II.1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C2700441:Cortex [Plant]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: "(Fig.3E"

Phrase: ")"

Phrase: "at the limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439801:limits [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
   916 E C3542948:Limited [Intellectual Product]

Phrase: "of detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "differing degrees of mosaicism"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0449286:degrees [Quantitative Concept]
   770   C0542560:degrees [Intellectual Product]
   737 E C0441889:Degree [Qualitative Concept]
   737 E C1561545:degree [Quantitative Concept]
   737 E C2348088:Degree [Quantitative Concept]

Phrase: "between these two tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.74: View larger version (62K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(62K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.75: (A) Schematic representation of asPCR using both forward and reverse allele-specific primers. 

Phrase: "(A) Schematic representation of asPCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse allele-specific primers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   886   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.76: For clarity, allele-specific bases highlighted on primers are all displayed in sense orientation. 

Phrase: "For clarity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0486588:Clarity [Clinical Attribute]
  1000   C3272888:Clarity [Laboratory Procedure]
   928 E C2963144:Clear [Qualitative Concept]

Phrase: "allele-specific bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   827   C0178499:bases [Chemical Viewed Functionally]
   827   C1626935:Bases [Quantitative Concept]
   793 E C0002055:base [Inorganic Chemical]
   793 E C1527178:Basis [Functional Concept]
   793 E C1874451:Basis [Pharmacologic Substance]
   793 E C1880279:Base [Biomedical or Dental Material]
   743 E C0205112:Basal [Spatial Concept]
   734 E C0016617:Foundation [Organization]

Phrase: "highlighted on primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "all"

Phrase: "displayed in sense orientation."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1883001:Sense Orientation [Functional Concept]
   770   C0029266:Orientation [Mental Process]
   770   C0036658:sense [Organ or Tissue Function]
   770   C0870432:displayed [Functional Concept]
   770   C1704322:orientation [Spatial Concept]
   770   C1704972:Orientation [Spatial Concept]
   770   C3539923:Orientation [Intellectual Product]
   737 E C1705417:Display [Manufactured Object]
Processing 00000000.tx.77: (B) Demonstrates the results of asPCR between wild-type P436 (CCA) or mutant Q436 (CAA) and 3' SNP (dbSNP 165935, C/T). 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Demonstrates"

Phrase: "the results of asPCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "between wild-type P436"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(CCA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220668:CCA [Congenital Abnormality]

Phrase: "or"

Phrase: "mutant Q436"

Phrase: "(CAA)"

Phrase: "and"

Phrase: "3' SNP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:Polymorphism [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(dbSNP 165935,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710090:dbSNP [Intellectual Product]

Phrase: "C/T)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.78: DNA from normal individuals (obtained from CEPH) demonstrate all three potential wild-type haplotype combinations (CT/CT, CT/CC, CC/CC). 

Phrase: "DNA from normal individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "obtained from CEPH)"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "all three potential wild-type haplotype combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0453882:Combinations [Manufactured Object]
   766 E C0205195:Combination [Qualitative Concept]
   766 E C1947911:Combination [Physical Object]

Phrase: "(CT/CT,"

Phrase: "CT/CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "CC/CC"

Phrase: ")."
Processing 00000000.tx.79: Individual II.1 is shown to have three alleles including the mutated allele shared with offspring III.2. 

Phrase: "Individual II.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "three alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the mutated allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "shared with offspring III.2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237876:shared [Social Behavior]
   760   C0439070:III [Intellectual Product]
   760   C0680063:Offspring [Family Group]
   760   C1522138:Shared [Functional Concept]
   760   C1705160:III [Qualitative Concept]
Processing 00000000.tx.80: Allele-specific product sizes range between 1287 and 1291bp depending upon primer pair, while the internal control product is 972bp (PL=peripheral lymphocyte DNA, CC=cerebral cortex DNA, NTC=no template control). 

Phrase: "Allele-specific product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:SIZES [Spatial Concept]

Phrase: "range between 1287"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514721:Range [Quantitative Concept]
   790   C2348147:Range [Quantitative Concept]
   790   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "1291bp"

Phrase: "depending upon primer pair,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1709450:Pair [Qualitative Concept]
   737   C0725813:depend [Medical Device]

Phrase: "while"

Phrase: "the internal control product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]
   734   C0597937:internal control [Mental Process]

Phrase: "is"

Phrase: "972bp"

Phrase: "(PL=peripheral lymphocyte DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CC=cerebral cortex DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "NTC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2755952:NTC [Cell Component]

Phrase: "="

Phrase: "no template control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.81: (C) Demonstrates the results of haplotype analysis including six microsatellite markers that frame the PSEN1 gene, spanning 1Mb. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Demonstrates"

Phrase: "the results of haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "six microsatellite markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0005516:Marker [Clinical Attribute]

Phrase: "that"

Phrase: "frame"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080089:Frame [Nucleotide Sequence]
  1000   C0180979:Frame [Medical Device]
  1000   C1705858:Frame [Manufactured Object]

Phrase: "the PSEN1 gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "1Mb."
Processing 00000000.tx.82: The table includes results of the asPCR shown in (A) and (B) as nucleotides, all other results refer to PCR fragment sizes. 

Phrase: "The table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "results of the asPCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in (A)"

Phrase: "and ("

Phrase: "B) as nucleotides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "all"

Phrase: "other results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "refer to PCR fragment sizes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0205543:refer [Functional Concept]
   760   C0332255:fragment [Functional Concept]
   760   C0456389:SIZES [Spatial Concept]
   760   C0677874:pCR [Finding]
   760   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.83: Arbitrary haplotype names (A, A*, B, C and D) have been assigned and are referred to in the text. 

Phrase: "Arbitrary haplotype names"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027365:Name [Intellectual Product]
   827   C1547383:Name [Intellectual Product]

Phrase: "(A,"

Phrase: "A"

Phrase: "*,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205396:Discernible [Qualitative Concept]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "and"

Phrase: "are"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C1883351:To [Qualitative Concept]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.84: Chromosomal location of markers and SNPs is given to the nearest kb relative to the PSEN1 translation start site.  

Phrase: "Chromosomal location of markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450429:Location [Spatial Concept]
   770   C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0752046:SNPs [Nucleotide Sequence]
   966 E C1527094:SNP [Conceptual Entity]

Phrase: "is"

Phrase: "given to the nearest kb"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205107:Nearest [Spatial Concept]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C3244317:given [Intellectual Product]
   726 E C1947971:Give [Functional Concept]

Phrase: "relative to the PSEN1 translation start site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.85: In addition to quantitative phosphorimaging of ASOH products, a new application for allele-specific minor groove binder (MGB) probes (13) was employed. 

Phrase: "In addition to quantitative phosphorimaging"

Phrase: "of ASOH products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]

Phrase: "a new application for allele-specific minor groove binder (MGB) probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0185125:Application [Health Care Activity]
   739   C1947919:Application [Intellectual Product]
   739   C2347934:Application [Intellectual Product]
   739   C3539080:APPLICATION [Quantitative Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "was"

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.86: An increase in the cycle threshold difference [delta () Ct] between a Q436 specific probe and a reference probe specific for M129 of the human PRNP gene was detected in DNA from both tissues of individual II.1 (cerebral cortex and peripheral lymphocytes) compared with the heterozygote offspring III.2. 

Phrase: "An increase in the cycle threshold difference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "[delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: "Ct] between a Q436 specific probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "a reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "specific for M129 of the human PRNP gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "detected in DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "from both tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "of individual II.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "(cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "peripheral lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: ")"

Phrase: "compared with the heterozygote offspring III.2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0019425:Heterozygote [Organism Attribute]
   748   C0439070:III [Intellectual Product]
   748   C0680063:Offspring [Family Group]
   748   C1705160:III [Qualitative Concept]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.87: Using the comparative Ct method (14) (Ct), the estimated degrees of mosaicism in peripheral lymphocytes and cerebral cortex were 7.7% (ASOH 10.5%) and 14.4% (ASOH 16.5%) of the locus, respectively (Fig.6). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the comparative Ct method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(14"

Phrase: ")"

Phrase: "(Ct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the estimated degrees of mosaicism"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0449286:degrees [Quantitative Concept]
   760   C0542560:degrees [Intellectual Product]
   726 E C0441889:Degree [Qualitative Concept]
   726 E C1561545:degree [Quantitative Concept]
   726 E C2348088:Degree [Quantitative Concept]

Phrase: "in peripheral lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "7.7%"

Phrase: "(ASOH 10.5%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0002085:Allele [Gene or Genome]
   799   C0020202:Hybridisation [Genetic Function]
   799   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0205369:Specific [Qualitative Concept]
   799   C1300517:Hybridization [Laboratory Procedure]
   799   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "14.4%"

Phrase: "(ASOH 16.5%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0002085:Allele [Gene or Genome]
   799   C0020202:Hybridisation [Genetic Function]
   799   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0205369:Specific [Qualitative Concept]
   799   C1300517:Hybridization [Laboratory Procedure]
   799   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "of the locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "respectively"

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.88: View larger version (29K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.89: (AC) Real-time PCR replicate results using an internal control probe (M129 PRNP, blues) and Q436 PSEN1 (reds) for individuals II.1 and III.2, showing cycle number against change in fluorescence (Rn). 

Phrase: "(AC) Real-time PCR replicate results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C1274040:Result [Functional Concept]
   766   C1546471:Result [Idea or Concept]
   766   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an internal control probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]
   734   C0597937:internal control [Mental Process]

Phrase: "(M129 PRNP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "blues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Q436 PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(reds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332575:Red [Finding]
   966   C1260956:Red [Qualitative Concept]

Phrase: ")"

Phrase: "for individuals II.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "and"

Phrase: "III.2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cycle number against change"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Rn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540639:RN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.90: Ct values are as follows: (A) CtIII.2=1.82, (B) CtII.1CC=3.62, (C) CtII.1PL=4.52. 

Phrase: "Ct values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(A) CtIII.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1825406:A-2 [Gene or Genome]

Phrase: "=1.82,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(B) CtII.1CC"

Phrase: "=3.62,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(C) CtII.1PL"

Phrase: "=4.52."
Processing 00000000.tx.91: Increase in Ct when compared with heterozygote (Q436=50% of locus) individual II.1 are: CtII.1PL=4.521.82=2.7 (1/2)2.7=0.154; 

Phrase: "Increase in Ct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]

Phrase: "when"

Phrase: "compared with heterozygote"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0019425:Heterozygote [Organism Attribute]
   790   C1707455:Compared [Activity]

Phrase: "(Q436"

Phrase: "=50% of locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1708726:Locus [Gene or Genome]

Phrase: ")"

Phrase: "individual II.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "are"

Phrase: ":"

Phrase: "CtII.1PL"

Phrase: "=4.521.82"

Phrase: "=2.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(1/2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "2.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "=0.154"

Phrase: ";"
Processing 00000000.tx.92: therefore, Q436=7.7% of locus. 

Phrase: "therefore,"

Phrase: "Q436"

Phrase: "=7.7% of locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.93: CtII.1CC=3.621.82=1.8 (1/2)1.8=0.287; 

Phrase: "CtII.1CC"

Phrase: "=3.621.82"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "=1.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(1/2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "1.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "=0.287"

Phrase: ";"
Processing 00000000.tx.94: therefore, Q436=14.4% of locus (PL=peripheral lymphocytes, CC=cerebral cortex).   

Phrase: "therefore,"

Phrase: "Q436"

Phrase: "=14.4% of locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708726:Locus [Gene or Genome]

Phrase: "(PL=peripheral lymphocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024264:Lymphocytes [Cell]

Phrase: "CC=cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: ")."
Processing 00000000.tx.95: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  This is the first description of somatic and germline mosaicism in AD; 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This"

Phrase: "is"

Phrase: "the first description of somatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678257:Description [Idea or Concept]

Phrase: "and"

Phrase: "germline mosaicism in AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026578:Mosaicism [Organism Attribute]
   770   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   770   C2987512:mosaicism [Organism]

Phrase: ";"
Processing 00000000.tx.96: our index patient II.1 was negative for mutations in the PSEN1 gene when DNA extracted from her peripheral blood sample was sequenced; 

Phrase: "our index patient II.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0030705:*^patient [Patient or Disabled Group]
   812   C0918012:Index [Intellectual Product]
   812   C1552854:index [Idea or Concept]
   812   C1637833:% index [Quantitative Concept]

Phrase: "was"

Phrase: "negative for mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205160:Negative [Qualitative Concept]
   790   C1513916:Negative [Finding]
   790   C2825415:Negative [Conceptual Entity]
   790   C2825491:Negative [Qualitative Concept]

Phrase: "in the PSEN1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "when"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from her peripheral blood sample"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0178913:Blood sample [Body Substance]
   790   C0229664:peripheral blood [Body Substance]
           Blood
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0205100:Peripheral [Spatial Concept]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
   753   C3541890:EXTRACTED [Finding]
   748 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   719 E C2828366:Extract [Substance]

Phrase: "was"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: ";"
Processing 00000000.tx.97: however, the P436Q mutation was detected after direct sequencing of DNA extracted from her cerebral cortex, indicating that the mother was a somatic mosaic for this mutation. 

Phrase: "however,"

Phrase: "the P436Q mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "detected after direct sequencing of DNA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0162326:DNA sequencing [Nucleotide Sequence]
   783   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439851:Direct [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
   753   C1947931:Direct [Qualitative Concept]

Phrase: "extracted from her cerebral cortex,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "indicating"

Phrase: "that"

Phrase: "the mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0026591:Mother [Family Group]
   944 E C1826438:MATER [Gene or Genome]
   944 E C2347083:Maternal [Family Group]

Phrase: "was"

Phrase: "a somatic mosaic for this mutation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439750:Mosaic [Spatial Concept]
   753   C0700058:Mosaic [Intellectual Product]
   753   C2987512:Mosaic [Organism]
Processing 00000000.tx.98: This was confirmed by detailed haplotype analysis; 

Phrase: "This"

Phrase: "was"

Phrase: "confirmed by detailed haplotype analysis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0018591:Haplotype [Organism Attribute]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1522508:Detailed [Qualitative Concept]
   760   C1524024:analysis [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.99: in particular, combined microsatellite and SNP haplotype data demonstrate that the affected daughter (III.2) inherited the mutant haplotype designated A*, whereas her two unaffected siblings (III.1, III.4) inherited the progenitor haplotype A from the mother, which differs only by the presence of the P436Q missense mutation on haplotype A*. 

Phrase: "in particular, combined microsatellite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519302:Microsatellite [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "SNP haplotype data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]
   717   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the affected daughter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011011:Daughter [Family Group]
   861   C1610715:Daughter [Intellectual Product]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "the mutant haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "A"

Phrase: "*,"

Phrase: "whereas"

Phrase: "her two unaffected siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: "(III.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "III.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "the progenitor haplotype A from the mother,"

Phrase: "which"

Phrase: "differs"

Phrase: "only by the presence of the P436Q missense mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0599155:Missense Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C0205171:Only [Quantitative Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1720467:Only [Intellectual Product]

Phrase: "on haplotype A"

Phrase: "*."
Processing 00000000.tx.100: This is an important finding as it may be that many patients with AD harbour causative pathogenic somatic mutations expressed in neural tissue, that are undetectable on conventional laboratory examination of DNA extracted from peripheral blood lymphocytes. 

Phrase: "This"

Phrase: "is"

Phrase: "an important finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "as"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "that"

Phrase: "many patients with AD harbour causative pathogenic somatic mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030705:Patients [Patient or Disabled Group]

Phrase: "expressed in neural tissue,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0027757:Neural tissue [Tissue]
       E   NERVE
   833   C1762608:Neural tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C0599851:Neural [Functional Concept]
   770   C1547928:Tissue [Intellectual Product]
   715 E C0027740:Nerve [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "are"

Phrase: "undetectable on conventional laboratory examination of DNA"

Phrase: "extracted from peripheral blood lymphocytes."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   828   C1518997:Peripheral Blood Lymphocyte [Cell]
   806   C0229664:peripheral blood [Body Substance]
           Blood
   790   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0205100:Peripheral [Spatial Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
Processing 00000000.tx.101: Our findings also demonstrate that the mother (II.1) is likely to be both a germline and somatic mosaic, and thus we were able to detect the P436Q mutation in DNA extracted from her daughter's blood as the latter was a heterozygote. 

Phrase: "Our findings also"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0026591:Mother [Family Group]
   944 E C1826438:MATER [Gene or Genome]
   944 E C2347083:Maternal [Family Group]

Phrase: "(II.1"

Phrase: ")"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "both a germline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017473:Germ Line [Cell]

Phrase: "and"

Phrase: "somatic mosaic,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439750:Mosaic [Spatial Concept]
   861   C0700058:Mosaic [Intellectual Product]
   861   C2987512:Mosaic [Organism]

Phrase: "and"

Phrase: "thus"

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the P436Q mutation in DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "extracted from her daughter's blood"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0011011:Daughter [Family Group]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0229664:Blood [Body Substance]
   760   C1610715:Daughter [Intellectual Product]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "as the latter"

Phrase: "was"

Phrase: "a heterozygote."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygote [Organism Attribute]
Processing 00000000.tx.102: Germ cell lineage is established during gastrulation, as is the trilaminar embryo. 

Phrase: "Germ cell lineage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0282637:Cell Lineage [Idea or Concept]
   827   C1881379:Lineage [Conceptual Entity]
   734   C0017471:Germ cell [Cell]
   734   C1517530:Germ Cell [Cell]

Phrase: "is"

Phrase: "established during gastrulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0259902:Gastrulation [Organism Function]
   790   C0443211:Established [Qualitative Concept]
   790   C1272684:Established [Qualitative Concept]

Phrase: "as is"

Phrase: "the trilaminar embryo."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0231013:Trilaminar embryo [Embryonic Structure]
  1000   C1282900:Trilaminar embryo [Embryonic Structure]
  1000   C1288340:Trilaminar embryo [Embryonic Structure]
   861   C0013935:Embryo [Embryonic Structure]
   861   C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.103: The central nervous system is derived from the ectoderm whereas hemopoietic stem cells are derived from the mesoderm. 

Phrase: "The central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "derived from the ectoderm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013574:Ectoderm [Embryonic Structure]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "whereas"

Phrase: "hemopoietic stem cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   983   C0018956:Hemopoietic stem cell [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hemopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "derived from the mesoderm."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025485:Mesoderm [Embryonic Structure]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.104: Therefore the mutation must have occurred before gastrulation, perhaps within the inner cell mass of the blastocyst or at some time prior to the second week of embryogenesis (15). 

Phrase: "Therefore"

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "must"

Phrase: "have"

Phrase: "occurred before gastrulation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0259902:Gastrulation [Organism Function]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "perhaps within the inner cell mass of the blastocyst"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   838   C1721028:Inner Cell Mass of Blastocyst [Cell]
           Blastocyst Inner Cell Mass
   790   C1283994:Inner cell mass [Embryonic Structure]
   742   C0005705:Blastocyst [Embryonic Structure]
   742   C0007634:Cell [Cell]
   742   C0205102:Inner [Spatial Concept]
   742   C0577559:Mass [Finding]
   742   C1269647:Cell [Cell]
   742   C1281743:Blastocyst [Embryonic Structure]
   742   C1281786:Blastocyst [Embryonic Structure]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3152252:Mass [Quantitative Concept]

Phrase: "or at some time"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "prior to the second week"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: "of embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.105: Tissue derived from the endodermal germ layer was unavailable for analysis. 

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "derived from the endodermal germ layer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0017472:Layer, Germ [Tissue]
   790   C0920502:Germ layer [Embryonic Structure]
   753   C0521461:Endodermal [Body Location or Region]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C1517528:Germ [Idea or Concept]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C3245521:derived [Idea or Concept]

Phrase: "was"

Phrase: "unavailable for analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0686905:Unavailable [Functional Concept]
Processing 00000000.tx.106: The P436Q mutation was originally described in an Australian family (16). 

Phrase: "The P436Q mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "originally"

Phrase: "described in an Australian family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015576:Family [Family Group]
   760   C0238711:AUSTRALIAN [Finding]
   760   C1552738:described [Idea or Concept]
   760   C1704727:Family [Conceptual Entity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.107: Despite clinical similarities observed in the affected individual in their pedigree and III.2, the genealogical data available for our pedigree suggests two separate mutation events and implicates a de novo somatic and germline mutation in individual II.1 (17). 

Phrase: "Despite clinical similarities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "observed in the affected individual"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027361:Individual [Population Group]
   760   C0237401:Individual [Human]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "in their pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:Pedigree [Intellectual Product]

Phrase: "and"

Phrase: "III.2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "the genealogical data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "available for our pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "two separate mutation events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: "and"

Phrase: "implicates"

Phrase: "a de novo somatic"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C2986476:Somatic [Qualitative Concept]
   734 E C0599444:soma [Cell Component]
   734 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   734   C1515568:de novo [Idea or Concept]
   721 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "germline mutation in individual II.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0206530:Germ-Line Mutation [Genetic Function]
   790   C1705427:Germline Mutation [Cell or Molecular Dysfunction]
   753   C0017473:Germ Line [Cell]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.108: The parents of individual II.1 died at the age of 73 (I.1) and 37 (I.2), without any reported signs of dementia; 

Phrase: "The parents of individual II.1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0030551:Parents [Family Group]
   719 E C2699423:Parent [Conceptual Entity]

Phrase: "died at the age of 73"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011065:Died [Organism Function]
   753   C1546956:Died [Finding]

Phrase: "(I.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1425233:I-1 [Gene or Genome]
  1000   C3540559:I-1 [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "and"

Phrase: "37"

Phrase: "(I.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "without any reported signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.109: the latter from myocardial infarction. 

Phrase: "the latter from myocardial infarction."
Processing 00000000.tx.110: I.2 had six siblings, none of whom had dementia. 

Phrase: "I.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "had"

Phrase: "six siblings,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037047:Siblings [Family Group]
   827 E C1611273:Sibling [Intellectual Product]

Phrase: "none of whom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456148:None [Quantitative Concept]
   790   C0549184:None [Quantitative Concept]

Phrase: "had"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.111: In addition, the four living siblings of II.1 are as yet unaffected in their sixth decade, one sibling died at birth (II.7) and the other at the age of 35 in an accident (II.6). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the four living siblings of II.1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0037047:Siblings [Family Group]
   714 E C1611273:Sibling [Intellectual Product]

Phrase: "are as yet unaffected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1551058:Are [Quantitative Concept]
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "in their sixth decade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "one sibling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037047:Sibling [Family Group]
   861   C1611273:Sibling [Intellectual Product]

Phrase: "died at birth"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   790   C0005615:Birth [Organism Function]
   790   C0011065:Died [Organism Function]
   790   C1546956:Died [Finding]
   790   C1550722:birth [Idea or Concept]
   790   C3245487:birth [Intellectual Product]
   734 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   734 E C0314603:Genetic [Functional Concept]
   734 E C0454729:Natal [Geographic Area]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]
   706 E C0035150:Reproduction [Organism Function]
   706 E C0079946:origin [Classification]
   706 E C0439659:Origin [Temporal Concept]
   706 E C1550512:origin [Intellectual Product]

Phrase: "(II.7"

Phrase: ")"

Phrase: "and"

Phrase: "the other at the age of 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0001779:Age [Organism Attribute]

Phrase: "in an accident"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0000924:Accident, NOS [Injury or Poisoning]
  1000   C1961149:Accident [Phenomenon or Process]
   928 E C0521129:Accidental [Functional Concept]

Phrase: "(II.6"

Phrase: ")."
Processing 00000000.tx.112: More than 100 pathogenic mutations of PSEN1 have been reported in early-onset AD [PSEN1 mutations database (2004): http://molgen-www.uia.ac.be/ADmutations], and the majority of these exist around putative transmembrane domains of the presenilin 1 protein suggesting functional mutation hotspots (18). 

Phrase: "More than 100 pathogenic mutations of PSEN1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0026882:Mutations [Genetic Function]
   744   C0205172:More [Functional Concept]
   744   C0450254:Pathogenic [Organism]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "reported in early-onset AD [PSEN1 mutations database"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   764   C1833334:Early-onset [Finding]
   742   C0026882:Mutations [Genetic Function]
   742   C0242356:Database [Intellectual Product]
   742   C0332162:Onset [Qualitative Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C0993637:Data Base [Intellectual Product]
   742   C1279919:Early [Temporal Concept]
   742   C3496591:Reported [Clinical Attribute]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]
   708 E C3273238:Report [Intellectual Product]

Phrase: "(2004"

Phrase: ")"

Phrase: ":"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//molgen-www.uia.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1412573:AC [Gene or Genome]
   812   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3539770:AC [Gene or Genome]

Phrase: "be/"

Phrase: "ADmutations"

Phrase: "],"

Phrase: "and"

Phrase: "the majority of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "exist around putative transmembrane domains of the presenilin 1 protein"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   775   C1420776:TRANSMEMBRANE PROTEIN 1 [Gene or Genome]
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   757   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   757   C0162808:Protein Domains [Spatial Concept]
   741 E C1514562:Protein Domain [Amino Acid Sequence]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1167322:transmembrane [Cell Component]
   739   C2752508:transmembrane [Cell Component]
   739   C2987476:Exist [Conceptual Entity]
   726   C1519623:Transmembrane Domain [Amino Acid Sequence]
   706   C1880389:Domain [Functional Concept]
   706   C1883221:Domain [Conceptual Entity]
   706   C3541951:Domain [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "functional mutation hotspots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2986491:Hotspot [Nucleotide Sequence]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.113: Evidence of mechanistic mutational hotspots have also been reported for other genes, including the E200K mutation in PRNP, where this variation has been shown to have occurred in at least four separate occasions (19). 

Phrase: "Evidence of mechanistic mutational hotspots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported for other genes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017337:Genes [Gene or Genome]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the E200K mutation in PRNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "where"

Phrase: "this variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "occurred in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1709305:Occurred [Activity]
   799 E C2745955:OCCUR [Temporal Concept]

Phrase: "at least four separate occasions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   729   C0521114:Occasional [Temporal Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.114: Utilizing the presence of such hotspots for demonstrating mosaicism in the diagnosis of apparently sporadic disease would be greatly facilitated by the use of specific assays such as 5' nuclease MGB probe allelic discrimination, as described here. 

Phrase: "Utilizing"

Phrase: "the presence of such hotspots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for"

Phrase: "demonstrating"

Phrase: "mosaicism in the diagnosis of apparently sporadic disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0026578:Mosaicism [Organism Attribute]
   744   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   744   C2987512:mosaicism [Organism]

Phrase: "would"

Phrase: "be"

Phrase: "greatly"

Phrase: "facilitated by the use of specific assays"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C0457083:Use [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1947944:Use [Intellectual Product]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "such as 5' nuclease MGB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0179302:Binder [Medical Device]
   804   C1706253:Binder [Biomedical or Dental Material]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "allelic discrimination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012632:Discrimination [Mental Process]
   861   C2987623:Discrimination [Social Behavior]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here."
Processing 00000000.tx.115: However, screening of families with no family history of neurological disease, or those with a history that does not follow a Mendelian pattern, would be best approached by the sequencing of putative genes using DNA isolated from post-mortem brain tissue rather than peripheral lymphocytes. 

Phrase: "However,"

Phrase: "screening of families"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0015576:Families [Family Group]
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1704727:Family [Conceptual Entity]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]
   756 E C1305399:screen [Functional Concept]
   756 E C1705053:Screen [Medical Device]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with no family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "of neurological disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "those with a history"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "a Mendelian pattern,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "would"

Phrase: "be"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "approached by the sequencing of putative genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1294197:Gene Sequencing [Laboratory Procedure]
   748   C0017337:Genes [Gene or Genome]
   748   C1553778:Sequencing [Intellectual Product]
   748   C1561491:Sequencing [Functional Concept]
   714   C0449445:Approach [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "isolated from post-mortem brain tissue"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   820   C0444184:Postmortem tissue [Tissue]
   790   C0004398:postmortem [Diagnostic Procedure]
   790   C0440746:Brain tissue [Tissue]
   790   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   790   C0580205:Postmortem [Temporal Concept]
   790   C0848632:post mortem [Finding]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0040300:Tissue [Tissue]
   753   C0205409:Isolated [Functional Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1547928:Tissue [Intellectual Product]
   753   C1548221:Isolated [Idea or Concept]
   753   C1704687:Post [Manufactured Object]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "rather than"

Phrase: "peripheral lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.116: This is unlikely to be feasible in routine clinical genetic diagnostics, but will be important to ascertain on a research basis. 

Phrase: "This"

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "feasible in routine clinical genetic diagnostics,"

Phrase: "but"

Phrase: "will"

Phrase: "be"

Phrase: "important to"

Phrase: "ascertain on a research basis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.117: Determining the frequency of cases of sporadic early- or late-onset AD that may be accounted for by somatic mosaicism will inevitably depend upon the ability to detect such mutations, the availability of suitable post-mortem tissue and the patient selection criteria employed. 

Phrase: "Determining"

Phrase: "the frequency of cases of sporadic early-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "or"

Phrase: "late-onset AD"

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by somatic mosaicism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "will"

Phrase: "inevitably"

Phrase: "depend upon the ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C0725813:depend [Medical Device]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "such mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the availability of suitable post-mortem tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "and"

Phrase: "the patient selection criteria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242801:Selection Criteria [Qualitative Concept]
   827   C0243161:criteria [Intellectual Product]
   734   C0242802:Patient Selection [Research Activity]

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.118: In addition, apparently autosomal recessive AD may also be due to germline mosaicism in either parent and recurrence risk will be dependent on the level of this mosaicism. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "apparently autosomal recessive AD"

Phrase: "may"

Phrase: "also"

Phrase: "be due to germline mosaicism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0017473:Germ Line [Cell]
   760   C0026578:Mosaicism [Organism Attribute]
   760   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   760   C2987476:Be [Conceptual Entity]
   760   C2987512:mosaicism [Organism]
   760   C3146286:Due [Idea or Concept]

Phrase: "in either parent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030551:parent [Family Group]
   861   C2699423:Parent [Conceptual Entity]

Phrase: "and"

Phrase: "recurrence risk"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2986492:Recurrence Risk [Quantitative Concept]
   861   C0034897:Recurrence [Phenomenon or Process]
   861   C0035647:Risk [Qualitative Concept]
   861   C1458156:recurrence [Neoplastic Process]
   861   C2825055:Recurrence [Pathologic Function]
   789 E C2945760:Recurrent [Temporal Concept]

Phrase: "will"

Phrase: "be"

Phrase: "dependent on the level of this mosaicism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.119: In individual II.1 we describe degrees of mosaicism of 8% in peripheral lymphocytes and 14% in cerebral cortex, significantly delaying onset of disease in the index patient, and resulting in a quite different phenotype from her daughter III.2. 

Phrase: "In individual II.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "we"

Phrase: "describe"

Phrase: "degrees of mosaicism of 8%"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0449286:degrees [Quantitative Concept]
   760   C0542560:degrees [Intellectual Product]
   726 E C0441889:Degree [Qualitative Concept]
   726 E C1561545:degree [Quantitative Concept]
   726 E C2348088:Degree [Quantitative Concept]

Phrase: "in peripheral lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "14% in cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "significantly"

Phrase: "delaying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205421:Delay [Temporal Concept]

Phrase: "onset of disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0277793:disease onset [Temporal Concept]
   790   C0332162:Onset [Qualitative Concept]

Phrase: "in the index patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "resulting in a quite different phenotype"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0332294:Resulting in [Functional Concept]
   753   C0031437:Phenotype [Organism Attribute]
   753   C0678226:resulting [Functional Concept]
   753   C1285572:Phenotype [Laboratory Procedure]
   753   C1705242:Different [Qualitative Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "from her daughter III.2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0011011:Daughter [Family Group]
   827   C0439070:III [Intellectual Product]
   827   C1610715:Daughter [Intellectual Product]
   827   C1705160:III [Qualitative Concept]
Processing 00000000.tx.120: Assuming that the mosaicism of the P436Q mutation in PSEN1 accounts for this marked phenotypic variation and disease severity (8,9), extrapolation of our data suggests that very low levels of mosaicism could result in manifestation of clinical symptoms of disease within the expected lifetime of a patient. 

Phrase: "Assuming"

Phrase: "that"

Phrase: "the mosaicism of the P436Q mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026578:Mosaicism [Organism Attribute]
   753   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   753   C2987512:mosaicism [Organism]

Phrase: "in PSEN1 accounts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1551359:account [Idea or Concept]
   793   C2741673:Account # [Clinical Attribute]
   793   C2981730:Account [Classification]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "for this marked phenotypic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1836717:Phenotypic variation [Finding]
   827   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "disease severity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0521117:disease severity [Qualitative Concept]
   861   C0439793:Severity [Qualitative Concept]
   861   C2983285:Severity [Intellectual Product]
   789 E C0205082:Severe [Qualitative Concept]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "extrapolation of our data"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that very low levels of mosaicism"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "result in manifestation of clinical symptoms of disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   744   C0012634:Disease [Disease or Syndrome]
   744   C0205210:Clinical [Qualitative Concept]
   744   C0205319:manifestation [Functional Concept]
   744   C0683368:symptoms [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1457887:Symptoms [Sign or Symptom]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "within the expected lifetime"

Phrase: "of a patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.121: Therefore a proportion of late-onset AD, and other age-related neurodegenerative conditions, could be accounted for by this mechanism. 

Phrase: "Therefore"

Phrase: "a proportion of late-onset AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "other age-related neurodegenerative conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "could"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by this mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.122: The demonstration of a clear PSEN1 gene dosage effect in disease pathogenesis and phenotypic expression may also have relevance to therapeutic strategies in AD.  

Phrase: "The demonstration of a clear PSEN1 gene dosage effect"

Phrase: "in disease pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "phenotypic expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotypic expression [Organism Attribute]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "also"

Phrase: "have"

Phrase: "relevance to therapeutic strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevance [Qualitative Concept]

Phrase: "in AD."
Processing 00000000.tx.123: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  This work has the approval of the Institute of Neurology/National Hospital for Neurology and Neurosurgery Research Ethics Committee and the family of the index patient. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "the approval of the Institute of Neurology/National Hospital"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205540:Approval [Qualitative Concept]
   742   C2346845:Approval [Intellectual Product]

Phrase: "for Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "and"

Phrase: "Neurosurgery Research Ethics Committee"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0086911:Research Ethics Committee [Professional or Occupational Group]
   861   C0085546:Ethics Committee [Professional or Occupational Group]
   861   C0814851:Ethics, Research [Idea or Concept]
   812   C0015000:Ethics [Idea or Concept]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1527243:ethics [Idea or Concept]
   812   C2699414:Committee [Group]

Phrase: "and"

Phrase: "the family of the index patient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.124: To avoid cross-contamination from the index patient II.1, DNA was extracted from two separate blood samples taken at different times, and a single cerebral cortex sample, in different laboratories. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "cross-contamination from the index patient II.1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0259846:contamination [Human-caused Phenomenon or Process]
   744   C1881659:CONTAMINATION [Event]
   744   C2349974:Contamination [Idea or Concept]
   744   C2828360:Cross [Conceptual Entity]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from two separate blood samples"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0178913:blood samples [Body Substance]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0205448:Two [Quantitative Concept]
   753   C0229664:Blood [Body Substance]
   753   C0443299:Separate [Spatial Concept]
   753   C3541890:EXTRACTED [Finding]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]
   719 E C2828366:Extract [Substance]

Phrase: "taken at different times,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C1705242:Different [Qualitative Concept]
   770   C1883727:Taken [Conceptual Entity]
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   737 E C1515187:Take [Health Care Activity]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "a single cerebral cortex sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0370003:Sample [Substance]
   812   C2347026:Sample [Conceptual Entity]

Phrase: "in different laboratories."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.125: The P436Q mutation has been described previously in II.1 (12). 

Phrase: "The P436Q mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously in II.1"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.126: Replicates from both tissues of II.1 tested implicate somatic mosaicism as described, while all control individuals and unaffected family members tested, using various assays, never demonstrated the P436Q mutation. 

Phrase: "Replicates from both tissues of II.1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0040300:Tissues [Tissue]
   748   C0205173:Replicate [Functional Concept]
   748   C0205341:Replicate [Functional Concept]
   748   C1883725:Replicate [Qualitative Concept]
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "implicate"

Phrase: "somatic mosaicism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "while"

Phrase: "all control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "and"

Phrase: "unaffected family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "various assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "demonstrated"

Phrase: "the P436Q mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.127: DNA sequencing and SNP characterization DNA was extracted from peripheral blood lymphoctyes. 

Phrase: "DNA sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162326:DNA sequencing [Nucleotide Sequence]
  1000   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "and"

Phrase: "SNP characterization DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]

Phrase: "was"

Phrase: "extracted from peripheral blood lymphoctyes."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0229664:peripheral blood [Body Substance]
           Blood
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0205100:Peripheral [Spatial Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
Processing 00000000.tx.128: Sequencing was performed in both directions by the dideoxy chain terminator method using an Applied Biosystems (ABI) Prism 377 DNA sequencer. 

Phrase: "Sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "performed in both directions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439755:Directions [Spatial Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C0449738:Direction [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "by the dideoxy chain terminator method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Applied Biosystems (ABI) Prism 377 DNA sequencer."
Processing 00000000.tx.129: Specifically, for the mosaic individual, oligonucleotide primers were designed to amplify sequence flanking the P436Q mutation. 

Phrase: "Specifically,"

Phrase: "for the mosaic individual,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the P436Q mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.130: Amplicons were sequenced to identify positions of heterozygosity. 

Phrase: "Amplicons"

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "positions of heterozygosity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0733755:positions [Spatial Concept]
   706 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.131: Haplotype analysis Oligonucleotide primers were designed to perform asPCR (20) between the P436Q (CCACAA) transversion in exon 12 of PSEN1 (g. 71111C>A) and the SNP 1244bp 3' (dbSNP 165935). 

Phrase: "Haplotype analysis Oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "asPCR (20"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0002085:Allele [Gene or Genome]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0205369:Specific [Qualitative Concept]
   812   C0677874:pCR [Finding]
   812   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "between the P436Q"

Phrase: "(CCACAA"

Phrase: ")"

Phrase: "transversion in exon 12 of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0599157:Transversion [Cell or Molecular Dysfunction]

Phrase: "(g. 71111C"

Phrase: ">A)"

Phrase: "and"

Phrase: "the SNP 1244bp 3'"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:Polymorphism [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   804   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(dbSNP 165935"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710090:dbSNP [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: Allele frequencies for the SNP for 114 CEPH chromosomes were C=0.53, T=0.47. 

Phrase: "Allele frequencies for the SNP"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   778   C0017270:Frequencies, Allele [Quantitative Concept]
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "for 114 CEPH chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "were"

Phrase: "C=0.53,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553033:[c] [Quantitative Concept]

Phrase: "T=0.47."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.133: The integrity of all allele-specific amplifications were confirmed by duplexing with control oligonucleotide primers specifically targeted at intron 11 of the PSEN1 gene. 

Phrase: "The integrity of all allele-specific amplifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]

Phrase: "were"

Phrase: "confirmed by duplexing"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   756   C0444916:Duplex [Spatial Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "with control oligonucleotide primers specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "targeted at intron 11 of the PSEN1 gene."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1332838:Target Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521840:Targeted [Functional Concept]
   708 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.134: Primer sequences and amplification conditions are available on request. 

Phrase: "Primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "amplification conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "available on request."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]
Processing 00000000.tx.135: Extended haplotype analysis was performed using previously characterized microsatellite markers D14S268, D14S620, D14S1028, D14S77, D14S1004 and D14S1025. 

Phrase: "Extended haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously characterized microsatellite markers D14S268,"

Phrase: "D14S620,"

Phrase: "D14S1028,"

Phrase: "D14S77,"

Phrase: "D14S1004"

Phrase: "and"

Phrase: "D14S1025."
Processing 00000000.tx.136: Details of PCR fragment size range, number of alleles, primer sequences and degree of heterozygosity are available at http://www.genlink.wustl.edu/genethon_frame/chr14.html. 

Phrase: "Details of PCR fragment size range,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1522508:Details [Qualitative Concept]
   719 E C1561567:detail [Functional Concept]

Phrase: "number of alleles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "degree of heterozygosity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0441889:Degree [Qualitative Concept]
   790   C0449286:Degree [Quantitative Concept]
   790   C0542560:Degree [Intellectual Product]
   790   C1561545:degree [Quantitative Concept]
   790   C2348088:Degree [Quantitative Concept]

Phrase: "are"

Phrase: "available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.genlink.wustl.edu/genethon_frame/chr14.html."
Processing 00000000.tx.137: Fluorescently labelled PCR products were electrophoresed on an Applied Biosystems (ABI) Prism 377 DNA sequencer, and data analysis performed using Genescan software. 

Phrase: "Fluorescently labelled PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on an Applied Biosystems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185125:Applied [Health Care Activity]
   726   C0013855:electrophorese [Laboratory Procedure]

Phrase: "(ABI"

Phrase: ")"

Phrase: "Prism 377 DNA sequencer,"

Phrase: "and"

Phrase: "data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Genescan software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.138: Quantification by allelic discrimination using the 5' nuclease assay in conjunction with MGB probes MGB probes (ABI) were designed to detect the M129 allele of the PRNP gene and the mutant Q436 allele of the PSEN1 gene. 

Phrase: "Quantification by allelic discrimination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 5' nuclease assay in conjunction with MGB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0005507:Assay [Laboratory Procedure]
   739   C0243073:assay [Qualitative Concept]
   739   C1510438:Assay [Laboratory Procedure]

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "MGB probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "(ABI"

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the M129 allele of the PRNP gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "and"

Phrase: "the mutant Q436 allele of the PSEN1 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0002085:Allele [Gene or Genome]
           allelic gene
Processing 00000000.tx.139: An ABI Prism 7000 Sequence Detection System was used to perform relative quantification of the Q436 allele in the mosaic individual using the Ct method. 

Phrase: "An ABI Prism 7000 Sequence Detection System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "relative quantification of the Q436 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: "in the mosaic individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Ct method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.140: This assumed that the affected offspring (III.2) of our mosaic individual (II.1) is heterozygous for the Q436 allele. 

Phrase: "This"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that"

Phrase: "the affected offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "of our mosaic individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "(II.1"

Phrase: ")"

Phrase: "is"

Phrase: "heterozygous for the Q436 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019425:Heterozygous [Organism Attribute]
Processing 00000000.tx.141: Both the mosaic individual (II.1) and the affected offspring (III.2) were M129V PRNP genotype and therefore no correction for M129 allele copy number was necessary. 

Phrase: "Both"

Phrase: "the mosaic individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "(II.1"

Phrase: ")"

Phrase: "and"

Phrase: "the affected offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "M129V PRNP genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "therefore"

Phrase: "no correction for M129 allele copy number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C2736767:Correction number [Finding]
   748   C1705565:CORRECTION [Intellectual Product]
   748   C1947976:Correction [Functional Concept]

Phrase: "was"

Phrase: "necessary."
Processing 00000000.tx.142: Standard curves (data not shown) for individual III.2 showed that both probes had gradients within 0.1 of each other with least squares fit correlation coefficients greater than 0.99, demonstrating that Ct was constant relative to DNA quantity over the dynamic range of the experiment and satisfying criteria for the comparative Ct method of quantification. 

Phrase: "Standard curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "for individual III.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "had"

Phrase: "gradients within 0.1 of each other"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0812409:gradients [Quantitative Concept]
   714 E C0439182:% gradient [Quantitative Concept]

Phrase: "with least squares fit correlation coefficients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1707520:Correlation [Qualitative Concept]
   771   C1707429:*Coefficient [Quantitative Concept]

Phrase: "greater than 0.99,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "demonstrating"

Phrase: "that Ct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "was"

Phrase: "constant relative to DNA quantity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2699028:Relative Quantity [Quantitative Concept]
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "over the dynamic range"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986743:Dynamic Range [Quantitative Concept]
   861   C0729333:Dynamic [Functional Concept]
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "of the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "satisfying criteria for the comparative Ct method of quantification."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.143: The probes used showed >100-fold specificity, and dilution experiments (data not shown) indicated that amplification of the P436 allele did not prove to be limiting on Q436 probe fluorescence. 

Phrase: "The probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ">100-fold specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "dilution experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that amplification of the P436 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prove"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "limiting on Q436 probe fluorescence."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439801:limiting [Functional Concept]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.144: Quantification using allele-specific oligonucleotide hybridization ASOH was performed as previously described (21). 

Phrase: "Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "allele-specific oligonucleotide hybridization ASOH"

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.145: Quantification was performed using a STORM 840 phosphorimager (Molecular Dynamics). 

Phrase: "Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a STORM 840 phosphorimager"

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")."
Processing 00000000.tx.146: Q436 and P436 probe signals of the mosaic individual (II.1) were normalized against signals of affected (III.2) and unaffected offspring (III.1, III.4).  

Phrase: "Q436"

Phrase: "and"

Phrase: "P436 probe signals of the mosaic individual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710082:Signal [Phenomenon or Process]

Phrase: "(II.1"

Phrase: ")"

Phrase: "were"

Phrase: "normalized against signals of affected"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1882115:Normalized [Research Activity]
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "(III.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "unaffected offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "(III.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "III.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.147: ACKNOWLEDGEMENTS  We would like to thank Dr Sarah Lloyd, Professor Elizabeth Fisher and Dr Simon Mead for useful comments on the manuscript. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "would like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Sarah Lloyd,"

Phrase: "Professor Elizabeth Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325045:Fisher [Mammal]

Phrase: "and"

Phrase: "Dr Simon Mead for useful comments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678406:mead [Food]

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.148: We also thank the family for allowing us to undertake this study. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the family for allowing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undertake"

Phrase: "this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.149: We are grateful to Professor Martin Rossor who studied the family via an MRC Programme Grant No. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Professor Martin Rossor"

Phrase: "who"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the family via an MRC Programme Grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "No."
Processing 00000000.tx.150: G9626876, and referred the patients to the Neurogenetics Clinic. 

Phrase: "G9626876,"

Phrase: "and"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "the patients to the Neurogenetics Clinic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.151: This work was funded by the UK Medical Research Council. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded by the UK Medical Research Council."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0079816:Medical Research [Research Activity]
   778   C1556038:Medical Research [Professional or Occupational Group]
   774   C0681805:funded research [Research Activity]
   748   C0016820:funded [Quantitative Concept]
   748   C0035168:research [Research Activity]
   748   C0205476:Medical [Functional Concept]
   748   C0242481:Research [Research Activity]
   748   C1551807:Council [Population Group]
Processing 00000000.tx.152: S.J.T. is a UK Department of Health National Clinician Scientist.  

Phrase: "S."

Phrase: "J.T."

Phrase: "is"

Phrase: "a UK Department of Health National Clinician Scientist."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514958:Health Department [Health Care Related Organization]
   744   C1704729:Department [Organization]
Processing 00000000.tx.153: FOOTNOTES  * To whom correspondence should be addressed. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.154: Tel: +44 2078374888; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+44 2078374888"

Phrase: ";"
Processing 00000000.tx.155: Fax: +44 2078378047; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+44 2078378047"

Phrase: ";"
Processing 00000000.tx.156: Email: j.collinge{at}prion.ucl.ac.uk  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. etal. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "j.collinge{at}prion.ucl.ac.uk"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L. etal."
Processing 00000000.tx.157: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.158: Nature, 349, 704706.[CrossRef][ISI][Medline] Alzheimer's Disease Collaborative Group. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704706."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alzheimer's Disease Collaborative Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
Processing 00000000.tx.159: (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The structure of the presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "(S182"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418985:S182 [Gene or Genome]
  1000   C2986918:S182 [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "identification of six novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in early onset AD families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.160: Nat. 

Phrase: "Nat."
Processing 00000000.tx.161: Genet., 11, 219222.[ISI][Medline] Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "219222."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T. etal."
Processing 00000000.tx.162: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.163: Nature, 376, 775778.[CrossRef][ISI][Medline] Haass, C. and Steiner, H. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775778."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haass,"

Phrase: "C."

Phrase: "and"

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.164: (2002) Alzheimer disease gamma-secretase: a complex story of GxGD-type presenilin proteases. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Alzheimer disease gamma-secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "a complex story of GxGD-type presenilin proteases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1547707:Story [Geographic Area]
Processing 00000000.tx.165: Trends Cell. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.166: Biol., 12, 556562.[CrossRef][ISI][Medline] van Duijn, C.M., De Knijff, P., Cruts, M., Wehnert, A., Havekes, L.M., Hofman, A. and van Broeckhoven, C. 

Phrase: "Biol.,"

Phrase: "12,"

Phrase: "556562."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "De Knijff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.167: (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E4 allele in a population-based study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]

Phrase: "of early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.168: Nat. 

Phrase: "Nat."
Processing 00000000.tx.169: Genet., 7, 7478.[ISI][Medline] Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "7478."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D.E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205396:Discernible [Qualitative Concept]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.170: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.171: Science, 261, 921923.[ISI][Medline] Kennedy, J.L., Farrer, L.A., Andreasen, N.C., Mayeux, R. and George-Hyslop, P. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921923."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kennedy,"

Phrase: "J.L., Farrer,"

Phrase: "L.A.,"

Phrase: "Andreasen,"

Phrase: "N.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2349138:N/C [Quantitative Concept]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.172: (2003) The genetics of adult-onset neuropsychiatric disease: complexities and conundra? 

Phrase: "(2003"

Phrase: ")"

Phrase: "The genetics of adult-onset neuropsychiatric disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0019247:genetics disease [Disease or Syndrome]
   748   C0017398:Genetics [Biomedical Occupation or Discipline]
   748   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "complexities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C0439855:Complex [Qualitative Concept]
   916   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "conundra?"
Processing 00000000.tx.173: Science, 302, 822826.[Abstract/Free FullText] Dipple, K.M. and McCabe, E.R. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "822826."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dipple,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "McCabe,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.174: (2000) Phenotypes of patients with simple Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Phenotypes of patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0031437:Phenotypes [Organism Attribute]
   756 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "with simple Mendelian disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1285355:Mendelian disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]

Phrase: "are"

Phrase: "complex traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]

Phrase: ":"

Phrase: "thresholds,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:thresholds [Qualitative Concept]

Phrase: "modifiers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "systems dynamics."
Processing 00000000.tx.175: Am. 

Phrase: "Am."
Processing 00000000.tx.176: J. 

Phrase: "J."
Processing 00000000.tx.177: Hum. 

Phrase: "Hum."
Processing 00000000.tx.178: Genet., 66, 17291735.[CrossRef][ISI][Medline] Gottlieb, B., Beitel, L.K. and Trifiro, M.A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "66,"

Phrase: "17291735."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gottlieb,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Beitel,"

Phrase: "L.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Trifiro,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.179: (2001) Somatic mosaicism and variable expressivity. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Somatic mosaicism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "and"

Phrase: "variable expressivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1861403:Variable expressivity [Finding]
Processing 00000000.tx.180: Trends Genet., 17, 7982.[CrossRef][ISI][Medline] Geller, L.N. and Potter, H. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "17,"

Phrase: "7982."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Geller,"

Phrase: "L.N."

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.181: (1999) Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Chromosome missegregation"

Phrase: "and"

Phrase: "trisomy 21 mosaicism in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026578:Mosaicism [Organism Attribute]
   753   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   753   C2987512:mosaicism [Organism]
Processing 00000000.tx.182: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.183: Dis., 6, 167179.[CrossRef][ISI][Medline] Ball, M.J. and Murdoch, G.H. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "6,"

Phrase: "167179."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Murdoch,"

Phrase: "G.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.184: (1997) Neuropathological criteria for the diagnosis of Alzheimer's disease: are we really ready yet? 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuropathological criteria for the diagnosis of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: ":"

Phrase: "are"

Phrase: "we really ready yet?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C1318963:Readiness [Finding]
Processing 00000000.tx.185: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.186: Aging, 18, S312.[CrossRef][ISI][Medline] Houlden, H., Baker, M., McGowan, E., Lewis, P., Hutton, M., Crook, R., Wood, N.W., Kumar-Singh, S., Geddes, J., Swash, M. etal. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "18,"

Phrase: "S312."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "McGowan,"

Phrase: "E.,"

Phrase: "Lewis,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Kumar-Singh,"

Phrase: "S."

Phrase: ","

Phrase: "Geddes,"

Phrase: "J.,"

Phrase: "Swash,"

Phrase: "M. etal."
Processing 00000000.tx.187: (2000) Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Variant Alzheimer's disease with spastic paraparesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "and"

Phrase: "cotton wool plaques"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "is"

Phrase: "caused by PS-1 mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0026882:Mutations [Genetic Function]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to exceptionally high amyloid-beta concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0086045:Concentrations [Mental Process]
   766 E C1446561:Concentration [Quantitative Concept]
   716 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.188: Ann. 

Phrase: "Ann."
Processing 00000000.tx.189: Neurol., 48, 806808.[CrossRef][ISI][Medline] Allelic discrimination using the 5' nuclease assay: application note no. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "806808."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Allelic discrimination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012632:Discrimination [Mental Process]
   861   C2987623:Discrimination [Social Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 5' nuclease assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: ":"

Phrase: "application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0185125:Application [Health Care Activity]
  1000   C1947919:Application [Intellectual Product]
  1000   C2347934:Application [Intellectual Product]
  1000   C3539080:APPLICATION [Quantitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "no."
Processing 00000000.tx.190: 790910-004. 

Phrase: "790910-004."
Processing 00000000.tx.191: http://docs.appliedbiosystems.com/search.taf ABI Prism 7700 sequence detection system user bulletin #2 relative quantitation of gene expression P/N 4303859B stock no.777802-002 http://docs.appliedbiosystems.com/search.taf McLaren, A. 

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//docs.appliedbiosystems.com/search.taf ABI Prism 7700 sequence detection system user bulletin #2 relative quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   784   C1709793:Quantitation [Quantitative Concept]

Phrase: "of gene expression P/N 4303859B"

Phrase: "stock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710198:Stock [Idea or Concept]

Phrase: "no.777802-002 http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//docs.appliedbiosystems.com/search.taf McLaren,"

Phrase: "A."
Processing 00000000.tx.192: (2001) Mammalian germ cells: birth, sex, and immortality. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mammalian germ cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0017471:Germ Cells [Cell]
   896   C1512977:Mammalian Cell [Cell]
   867 E C1517530:Germ Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C1517528:Germ [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "birth,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
  1000   C0005615:Birth [Organism Function]
  1000   C1550722:birth [Idea or Concept]
  1000   C3245487:birth [Intellectual Product]
   944 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   944 E C0314603:Genetic [Functional Concept]
   944 E C0454729:Natal [Geographic Area]
   916 E C0035150:Reproduction [Organism Function]
   916 E C0079946:origin [Classification]
   916 E C0439659:Origin [Temporal Concept]
   916 E C1550512:origin [Intellectual Product]
   900 E C0559522:Genital [Body System]
   900 E C1546649:Genital [Intellectual Product]
   900 E C1550642:Genital [Body Substance]
   893 E C0205313:Original [Idea or Concept]
   893 E C2347409:Original [Occupational Activity]
   880 E C0598240:originality [Mental Process]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "immortality."
Processing 00000000.tx.193: Cell Struct. 

Phrase: "Cell Struct."
Processing 00000000.tx.194: Funct., 26, 119122.[CrossRef][ISI][Medline] Taddei, K., Kwok, J.B., Kril, J.J., Halliday, G.M., Creasey, H., Hallupp, M., Fisher, C., Brooks, W.S., Chung, C., Andrews, C. etal. 

Phrase: "Funct.,"

Phrase: "26,"

Phrase: "119122."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Taddei,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kwok,"

Phrase: "J.B.,"

Phrase: "Kril,"

Phrase: "J.J.,"

Phrase: "Halliday,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Creasey,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hallupp,"

Phrase: "M."

Phrase: ","

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Brooks,"

Phrase: "W.S.,"

Phrase: "Chung,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Andrews,"

Phrase: "C. etal."
Processing 00000000.tx.195: (1998) Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Two novel presenilin-1 mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Ser169Leu"

Phrase: "and"

Phrase: "Pro436Gln"

Phrase: ")"

Phrase: "associated with very early onset Alzheimer's disease."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   861   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1833334:Early-onset [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0442824:Very [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.196: Neuroreport, 9, 33353339.[ISI][Medline] Youssoufian, H. and Pyeritz, R.E. 

Phrase: "Neuroreport,"

Phrase: "9,"

Phrase: "33353339."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Youssoufian,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pyeritz,"

Phrase: "R.E."
Processing 00000000.tx.197: (2002) Mechanisms and consequences of somatic mosaicism in humans. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "consequences of somatic mosaicism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.198: Nat. 

Phrase: "Nat."
Processing 00000000.tx.199: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.200: Genet., 3, 748758.[CrossRef][ISI][Medline] Rogaeva, E.A., Fafel, K.C., Song, Y.Q., Medeiros, H., Sato, C., Liang, Y., Richard, E., Rogaev, E.I., Frommelt, P., Sadovnick, A.D. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "748758."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogaeva,"

Phrase: "E.A.,"

Phrase: "Fafel,"

Phrase: "K.C., Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872005:Song [Intellectual Product]

Phrase: "Y.Q., Medeiros,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sato,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Richard,"

Phrase: "E.,"

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Frommelt,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sadovnick,"

Phrase: "A.D. etal."
Processing 00000000.tx.201: (2001) Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Screening for PS1 mutations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0220908:Screening [Health Care Activity]
   770   C0220909:screening [Functional Concept]
   770   C1698960:screening [Intellectual Product]
   770   C1710031:Screening [Diagnostic Procedure]
   770   C1710477:SCREENING [Research Activity]

Phrase: "in a referral-based series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "of AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: ":"

Phrase: "21 novel mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.202: Neurology, 57, 621625.[Abstract/Free FullText] Lee, H.S., Sambuughin, N., Cervenakova, L., Chapman, J., Pocchiari, M., Litvak, S., Qi, H.Y., Budka, H., Del Ser, T., Furukawa, H. etal. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "57,"

Phrase: "621625."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "H.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sambuughin,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cervenakova,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chapman,"

Phrase: "J.,"

Phrase: "Pocchiari,"

Phrase: "M."

Phrase: ","

Phrase: "Litvak,"

Phrase: "S."

Phrase: ","

Phrase: "Qi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376586:Qi [Idea or Concept]

Phrase: "H.Y.,"

Phrase: "Budka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Del Ser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Furukawa,"

Phrase: "H. etal."
Processing 00000000.tx.203: (1999) Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial CreutzfeldtJakob disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Ancestral origins"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   861   C0079946:origins [Classification]
   861   C0439659:Origins [Temporal Concept]
   827 E C1550512:origin [Intellectual Product]
   789 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   789 E C0314603:Genetic [Functional Concept]
   777 E C0205313:Original [Idea or Concept]
   777 E C2347409:Original [Occupational Activity]
   768 E C0005615:Birth [Organism Function]
   768 E C0035150:Reproduction [Organism Function]
   768 E C1550722:birth [Idea or Concept]
   768 E C3245487:birth [Intellectual Product]
   755 E C0454729:Natal [Geographic Area]
   755 E C0559522:Genital [Body System]
   755 E C0598240:originality [Mental Process]
   755 E C1546649:Genital [Intellectual Product]
   755 E C1550642:Genital [Body Substance]

Phrase: "and"

Phrase: "worldwide distribution of the PRNP 200K mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0872250:protein distribution [Cell Function]
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "familial CreutzfeldtJakob disease."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   913   C0277558:Familial disease [Disease or Syndrome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.204: Am. 

Phrase: "Am."
Processing 00000000.tx.205: J. 

Phrase: "J."
Processing 00000000.tx.206: Hum. 

Phrase: "Hum."
Processing 00000000.tx.207: Genet., 64, 10631070.[CrossRef][ISI][Medline] Newton, C.R., Graham, A., Heptinstall, L.E., Powell, S.J., Summers, C., Kalsheker, N., Smith, J.C. and Markham, A.F. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "64,"

Phrase: "10631070."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "C.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Graham,"

Phrase: "A.,"

Phrase: "Heptinstall,"

Phrase: "L.E.,"

Phrase: "Powell,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Summers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0241301:Summer [Temporal Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kalsheker,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J.C."

Phrase: "and"

Phrase: "Markham,"

Phrase: "A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.208: (1989) Analysis of any point mutation in DNA. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Analysis of any point mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0796357:mutation analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.209: The amplification refractory mutation system (ARMS). 

Phrase: "The amplification refractory mutation system (ARMS)."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   812   C0026882:Mutation [Genetic Function]
   812   C0205269:Refractory [Functional Concept]
   812   C0449913:System [Functional Concept]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.210: Nucl. 

Phrase: "Nucl."
Processing 00000000.tx.211: Acids Res., 17, 25032516.[Abstract] Owen, F., Poulter, M., Collinge, J. and Crow, T.J. 

Phrase: "Acids Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "17,"

Phrase: "25032516."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Owen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Poulter,"

Phrase: "M."

Phrase: ","

Phrase: "Collinge,"

Phrase: "J."

Phrase: "and"

Phrase: "Crow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326391:Crow [Bird]
  1000   C1551958:Crow [Language]
  1000   C1555179:Crow [Population Group]

Phrase: "T.J."
Processing 00000000.tx.212: (1990) A codon 129 polymorphism in the PRIP gene. 

Phrase: "(1990"

Phrase: ")"

Phrase: "A codon 129 polymorphism in the PRIP gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0678951:gene polymorphism [Genetic Function]
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.213: Nucl. 

Phrase: "Nucl."
Processing 00000000.tx.214: Acids Res., 18, 3103.

Phrase: "Acids Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "18,"

Phrase: "3103."

